The American Journal of Surgery
Volume 186, Issue 4 , Pages 348-350 , October 2003

The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer

Presented at the Fourth Annual Meeting of the American Society of Breast Surgeons, Atlanta, Georgia, April 30–May 4, 2003

  • Susan H Lee, M.D.

      Affiliations

    • The Breast Health Center, Program in Women's Oncology, Women and Infants Hospital, 101 Dudley St., Providence, RI 02905, USA
    • ,
  • Maureen A Chung, M.D., Ph.D.

      Affiliations

    • The Breast Health Center, Program in Women's Oncology, Women and Infants Hospital, 101 Dudley St., Providence, RI 02905, USA
    • Department of Surgery, Brown University, Providence, RI, USA
    • Corresponding Author InformationCorresponding author. Department of Surgery, Rhode Island Hospital, 593 Eddy Street, APC 4, Providence, RI 02903. Tel.: +1-401-444-6158; fax: +1-401-444-6681.
    • ,
  • M.Ruhul Quddus, M.D.

      Affiliations

    • The Breast Health Center, Program in Women's Oncology, Women and Infants Hospital, 101 Dudley St., Providence, RI 02905, USA
    • Department of Pathology, Brown University, Providence, RI, USA
    • ,
  • Margaret M Steinhoff, M.D.

      Affiliations

    • The Breast Health Center, Program in Women's Oncology, Women and Infants Hospital, 101 Dudley St., Providence, RI 02905, USA
    • Department of Pathology, Brown University, Providence, RI, USA
    • ,
  • Blake Cady, M.D.

      Affiliations

    • The Breast Health Center, Program in Women's Oncology, Women and Infants Hospital, 101 Dudley St., Providence, RI 02905, USA
    • Department of Surgery, Brown University, Providence, RI, USA

Received 3 June 2003 ,Revised 21 June 2003

References 

  1. Singletary SE. Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer. Am J Surg. 2001;182:341–346
  2. Mamounas EP, Fisher B. Preoperative (neoadjuvant) chemotherapy in patients with breast cancer. Semin Oncol. 2001;28:389–399
  3. van der Hage JA, van de Velde CJ, Julien JP, et al.  Preoperative chemotherapy in primary operable breast cancer (results from the European Organization for Research and Treatment of Cancer trial 10902). J Clin Oncol. 2001;19:4224–4237
  4. Jain V, Landry M, Levine EA. The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma. Am Surg. 1996;62:162–165
  5. Makris A, Powles TJ, Allred DC, et al.  Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer (a pilot study). Breast Cancer Res Treat. 1999;53:51–59
  6. Schneider J, Lucas R, Sanchez J, et al.  Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer (correlation with the response to therapy and the expression of MDRI and LRP). Anticancer Res. 2000;20:4373–4377

PII: S0002-9610(03)00271-X

doi: 10.1016/S0002-9610(03)00271-X

The American Journal of Surgery
Volume 186, Issue 4 , Pages 348-350 , October 2003

Article Tools